Navigating the Future of the UK Artemisinin Combination Therapy Market

aggiunto articolo blog Altre informazioni

2025-12-17 13:11:05 -

The United Kingdom Artemisinin Combination Therapy (ACT) market is poised for steady growth over the decade from 2026 to 2036. Demand is expected to rise from approximately USD 45.2 million in 2026 to USD 91.8 million by 2036 — a CAGR of around 7.3%. Artemether + Lumefantrine is projected to remain the dominant product segment with a 42.5%...

0 Commenti 0 Condivisioni 8 Visualizzazioni